Structured Data | ["{\"@context\":\"https://schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https://bioneer.dk/\",\"url\":\"https://bioneer.dk/\",\"name\":\"Bioneer home - Bioneer\",\"isPartOf\":{\"@id\":\"https://bioneer.dk/#website\"},\"datePublished\":\"2015-12-14T04:09:47+00:00\",\"dateModified\":\"2025-03-21T13:04:05+00:00\",\"description\":\"Transforming scientific advancements into better Life Science solutions for tomorrowInnovative solutions for biotech and pharmaceutical companies.\",\"breadcrumb\":{\"@id\":\"https://bioneer.dk/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https://bioneer.dk/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https://bioneer.dk/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\"}]},{\"@type\":\"WebSite\",\"@id\":\"https://bioneer.dk/#website\",\"url\":\"https://bioneer.dk/\",\"name\":\"Bioneer\",\"description\":\"your trusted life science partner\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https://bioneer.dk/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}"] |
Internal Link(s) | ["http://bioneer.dk#content", "https://bioneer.dk/", "https://bioneer.dk/our-services/", "https://bioneer.dk/our-services/in-vitro-modelling/", "https://bioneer.dk/our-services/in-vitro-modelling/#cancer", "https://bioneer.dk/our-services/in-vitro-modelling/#immunology", "https://bioneer.dk/our-services/in-vitro-modelling/#cns", "https://bioneer.dk/our-services/in-vitro-modelling/#cns", "https://bioneer.dk/gene-editing-reprogramming/", "https://bioneer.dk/our-services/drug-formulation/", "https://bioneer.dk/our-services/drug-formulation/#dgm", "https://bioneer.dk/our-services/drug-formulation/#Biorelevant-in-vitro-models", "https://bioneer.dk/our-services/drug-formulation/#Cellular-Barrier-Models", "https://bioneer.dk/our-services/drug-formulation/#Peptides", "https://bioneer.dk/our-services/drug-formulation/#Small-Molecules", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/#recombinant-proteins-microbial", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/#recombinant-proteins-mammalian", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#Process-Development", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#GMP-Manufacturing-Microbial", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#non-gmp-manufacturing", "https://bioneer.dk/our-services/in-vitro-modelling/", "https://bioneer.dk/our-services/in-vitro-modelling/#cancer", "https://bioneer.dk/our-services/in-vitro-modelling/#immunology", "https://bioneer.dk/our-services/in-vitro-modelling/#cns", "https://bioneer.dk/our-services/in-vitro-modelling/gene-editing-reprogramming/", "https://bioneer.dk/our-services/drug-formulation/", "https://bioneer.dk/our-services/drug-formulation/#dgm", "https://bioneer.dk/our-services/drug-formulation/#Biorelevant-in-vitro-models", "https://bioneer.dk/our-services/drug-formulation/#Cellular-Barrier-Models", "https://bioneer.dk/our-services/drug-formulation/#Peptides", "https://bioneer.dk/our-services/drug-formulation/#Small-Molecules", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/#recombinant-proteins-microbial", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/#recombinant-proteins-mammalian", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#Process-Development", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#GMP-Manufacturing-Microbial", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#non-gmp-manufacturing", "https://bioneer.dk/our-rd-programs/", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#cns-modelling-assays", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#cancer-modelling", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#gene-editing", "https://bioneer.dk/our-rd-programs/drug-candidate-development/", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#recombinant-protein-expression", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#protein-refolding", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#Formulation-development", "https://bioneer.dk/our-rd-programs/strategic-rd-collaborations-projects/", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#cns-modelling-assays", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#cancer-modelling", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#gene-editing", "https://bioneer.dk/our-rd-programs/drug-candidate-development/", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#recombinant-protein-expression", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#protein-refolding", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#Formulation-development", "https://bioneer.dk/our-rd-programs/strategic-rd-collaborations-projects/", "https://bioneer.dk/about/", "https://bioneer.dk/about/#company", "https://bioneer.dk/about/#locations", "https://bioneer.dk/about/#leadership", "https://bioneer.dk/about/#gts", "https://bioneer.dk/bioneer/about/#company", "https://bioneer.dk/bioneer/about/#locations", "https://bioneer.dk/bioneer/about/#leadership", "https://bioneer.dk/bioneer/about/#gts", "https://bioneer.dk/news/", "https://bioneer.dk/news/", "https://bioneer.dk/news/#meet", "https://bioneer.dk/news/#publications", "https://bioneer.dk/news/#press", "https://bioneer.dk/bioneer/news/", "https://bioneer.dk/bioneer/news/#meet", "https://bioneer.dk/bioneer/news/#publications", "https://bioneer.dk/bioneer/news/#press", "https://bioneer.dk/careers/", "https://bioneer.dk/careers/#workingatbioneer", "https://bioneer.dk/careers/#positions", "https://bioneer.dk/careers/#team", "http://bioneer.dk/bioneer/careers/#workingatbioneer", "http://bioneer.dk/bioneer/careers/#positions", "http://bioneer.dk/bioneer/careers/#team", "https://bioneer.dk/bioneer/partners/", "https://bioneer.dk/contact/", "https://bioneer.dk/", "https://bioneer.dk/our-services/", "https://bioneer.dk/our-services/in-vitro-modelling/", "https://bioneer.dk/our-services/in-vitro-modelling/#cancer", "https://bioneer.dk/our-services/in-vitro-modelling/#immunology", "https://bioneer.dk/our-services/in-vitro-modelling/#cns", "https://bioneer.dk/our-services/in-vitro-modelling/#cns", "https://bioneer.dk/gene-editing-reprogramming/", "https://bioneer.dk/our-services/drug-formulation/", "https://bioneer.dk/our-services/drug-formulation/#dgm", "https://bioneer.dk/our-services/drug-formulation/#Biorelevant-in-vitro-models", "https://bioneer.dk/our-services/drug-formulation/#Cellular-Barrier-Models", "https://bioneer.dk/our-services/drug-formulation/#Peptides", "https://bioneer.dk/our-services/drug-formulation/#Small-Molecules", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/#recombinant-proteins-microbial", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/#recombinant-proteins-mammalian", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#Process-Development", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#GMP-Manufacturing-Microbial", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#non-gmp-manufacturing", "https://bioneer.dk/our-services/in-vitro-modelling/", "https://bioneer.dk/our-services/in-vitro-modelling/#cancer", "https://bioneer.dk/our-services/in-vitro-modelling/#immunology", "https://bioneer.dk/our-services/in-vitro-modelling/#cns", "https://bioneer.dk/our-services/in-vitro-modelling/gene-editing-reprogramming/", "https://bioneer.dk/our-services/drug-formulation/", "https://bioneer.dk/our-services/drug-formulation/#dgm", "https://bioneer.dk/our-services/drug-formulation/#Biorelevant-in-vitro-models", "https://bioneer.dk/our-services/drug-formulation/#Cellular-Barrier-Models", "https://bioneer.dk/our-services/drug-formulation/#Peptides", "https://bioneer.dk/our-services/drug-formulation/#Small-Molecules", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/#recombinant-proteins-microbial", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/#recombinant-proteins-mammalian", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#Process-Development", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#GMP-Manufacturing-Microbial", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/#non-gmp-manufacturing", "https://bioneer.dk/our-rd-programs/", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#cns-modelling-assays", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#cancer-modelling", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#gene-editing", "https://bioneer.dk/our-rd-programs/drug-candidate-development/", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#recombinant-protein-expression", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#protein-refolding", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#Formulation-development", "https://bioneer.dk/our-rd-programs/strategic-rd-collaborations-projects/", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#cns-modelling-assays", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#cancer-modelling", "https://bioneer.dk/our-rd-programs/cell-models-assay-development/#gene-editing", "https://bioneer.dk/our-rd-programs/drug-candidate-development/", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#recombinant-protein-expression", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#protein-refolding", "https://bioneer.dk/our-rd-programs/drug-candidate-development/#Formulation-development", "https://bioneer.dk/our-rd-programs/strategic-rd-collaborations-projects/", "https://bioneer.dk/about/", "https://bioneer.dk/about/#company", "https://bioneer.dk/about/#locations", "https://bioneer.dk/about/#leadership", "https://bioneer.dk/about/#gts", "https://bioneer.dk/bioneer/about/#company", "https://bioneer.dk/bioneer/about/#locations", "https://bioneer.dk/bioneer/about/#leadership", "https://bioneer.dk/bioneer/about/#gts", "https://bioneer.dk/news/", "https://bioneer.dk/news/", "https://bioneer.dk/news/#meet", "https://bioneer.dk/news/#publications", "https://bioneer.dk/news/#press", "https://bioneer.dk/bioneer/news/", "https://bioneer.dk/bioneer/news/#meet", "https://bioneer.dk/bioneer/news/#publications", "https://bioneer.dk/bioneer/news/#press", "https://bioneer.dk/careers/", "https://bioneer.dk/careers/#workingatbioneer", "https://bioneer.dk/careers/#positions", "https://bioneer.dk/careers/#team", "http://bioneer.dk/bioneer/careers/#workingatbioneer", "http://bioneer.dk/bioneer/careers/#positions", "http://bioneer.dk/bioneer/careers/#team", "https://bioneer.dk/bioneer/partners/", "https://bioneer.dk/contact/", "https://bioneer.dk/author/admin/", "https://bioneer.dk/our-services/in-vitro-modelling/", "https://bioneer.dk/our-services/drug-formulation", "https://bioneer.dk/our-services/recombinant-proteins-rd-services/", "https://bioneer.dk/our-services/recombinant-proteins-manufacturing/", "https://bioneer.dk/bioneer/news/", "https://bioneer.dk/bioneer/news/", "https://bioneer.dk/now-available-high-density-mea-assay-service/", "https://bioneer.dk/wp-content/uploads/2025/03/Mea-multielectrode-array-illustration.png", "https://bioneer.dk/now-available-high-density-mea-assay-service/", "https://bioneer.dk/now-available-high-density-mea-assay-service/", "https://bioneer.dk/author/signe/", "https://bioneer.dk/now-available-high-density-mea-assay-service/", "https://bioneer.dk/a-product-for-one-of-the-most-common-childhood-cancers/", "https://bioneer.dk/wp-content/uploads/2025/03/Ymabs-and-Bioneer.webp", "https://bioneer.dk/a-product-for-one-of-the-most-common-childhood-cancers/", "https://bioneer.dk/a-product-for-one-of-the-most-common-childhood-cancers/", "https://bioneer.dk/author/signe/", "https://bioneer.dk/a-product-for-one-of-the-most-common-childhood-cancers/", "https://bioneer.dk/chief-cdmo-officer/", "https://bioneer.dk/wp-content/uploads/2025/04/jobposting-CDMO.jpg", "https://bioneer.dk/chief-cdmo-officer/", "https://bioneer.dk/chief-cdmo-officer/", "https://bioneer.dk/author/signe/", "https://bioneer.dk/chief-cdmo-officer/", "https://bioneer.dk/senior-business-development-manager-in-vitro-modelling/", "https://bioneer.dk/wp-content/uploads/2023/12/DSC_1918-scaled-e1701955212348.jpg", "https://bioneer.dk/senior-business-development-manager-in-vitro-modelling/", "https://bioneer.dk/senior-business-development-manager-in-vitro-modelling/", "https://bioneer.dk/author/signe/", "https://bioneer.dk/senior-business-development-manager-in-vitro-modelling/", "https://bioneer.dk/bioneer/news/", "https://bioneer.dk/event/advancing-stem-cell-therapies-from-research-to-reality/", "https://bioneer.dk/event/advancing-stem-cell-therapies-from-research-to-reality/", "https://bioneer.dk/bioneer/privacy-policy/", "https://bioneer.dk/bioneer/newsletter/", "https://bioneer.dk/index.php/privacy-policy/", "http://bioneer.dk", "http://bioneer.dk"] |